1. L. L. Brunton, J. S. Lozo, and K. L. Parker. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 11th edn. McGraw-Hill Medical, New York, NY, 2006.
2. C. F. Lacy, L. L. Armstrong, M. P. Goldman, and L. L. Lance. Drug Information Handbook. A Comprehensive Resource for all Clinicians and Healthcare Professionals, 17th edn. Lexi-Comp, Hudson, OH, 2008–2009.
3. L. Z. Benet. Multiple dosing half-life. A composite term useful in designing therapeutic regimens. Presented at The Third Japanese–American Conference on Pharmacokinetics and Biopharmaceutics, Kyoto, Japan (1985), as available through reference 4.
4. J. G. Wagner. Dosage intervals based on mean residence times. J. Pharm. Sci. 76:35–38 (1987). doi: 10.1002/jps.2600760111 .
5. P. Veng-Pedersen, and N. B. Modi. Optimal extravascular dosing intervals. J. Pharmacokinet. Biopharm. 19:405–412 (1991). doi: 10.1007/BF01061664 .